Of alphas and betas: Distinct and overlapping functions of STAT3 isoforms

Frontiers in Bioscience

Volumn 13, Issue 17, 2008, Pages 6501-6514

  Dewilde, Sarah ^a   Vercelli, Alessandro ^a   Chiarle, Roberto ^a   Poli, Valeria ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Acute Phase Response factor; Astrocyte; Cytokine Signaling; GFAP; Nodose; Review; STAT; STAT3; STAT3alpha; STAT3beta

Indexed keywords

MUS;

CYTOKINE; GLIAL FIBRILLARY ASTROCYTIC PROTEIN, MOUSE; ISOPROTEIN; NERVE PROTEIN; RECOMBINANT PROTEIN; STAT3 PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL; ASTROCYTE; CYTOLOGY; GENETICS; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; NERVE CELL; PHYSIOLOGY; REVIEW;

ALTERNATIVE SPLICING; ANIMALS; ASTROCYTES; CYTOKINES; HUMANS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEURONS; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; STAT3 TRANSCRIPTION FACTOR;

EID: 52049124749     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3170     Document Type: Article

References (77)

1. Wegenka, U. M., J. Buschmann, C. Lutticken, P. C. Heinrich and F. Horn: Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 13, 276-88 (1993) (Pubitemid 23006905)
2. Akira, S., Y. Nishio, M. Inoue, X. J. Wang, S. Wei, T. Matsusaka, K. Yoshida, T. Sudo, M. Naruto and T. Kishimoto: Molecular cloning of APRF, a novel IFNstimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77, 63-71 (1994)
3. Zhong, Z., Z. Wen and J. E. Darnell, Jr.: Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95-8 (1994) (Pubitemid 24144493)
4. Wegenka, U. M., C. Lutticken, J. Buschmann, J. Yuan, F. Lottspeich, W. Muller-Esterl, C. Schindler, E. Roeb, P. C. Heinrich and F. Horn: The interleukin-6-activated acutephase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol Cell Biol 14, 3186-96 (1994) (Pubitemid 24132732)
5. Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto and S. Akira: Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 94, 3801-4 (1997) (Pubitemid 27180453)
6. Poli, V.: STAT3 function in vivo. Signal Transducers and Activators of Transcription (STATs), D. Sehgal, Ed., Kluwer Academic Publishers, 493-512 (2003).
7. Bowman, T., R. Garcia, J. Turkson and R. Jove: STATs in oncogenesis. Oncogene 19, 2474-88 (2000) (Pubitemid 30339203)
8. Lee, C. K., R. Raz, R. Gimeno, R. Gertner, B. Wistinghausen, K. Takeshita, R. A. DePinho and D. E. Levy: STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17, 63-72 (2002) (Pubitemid 34874619)
9. Cuesta, N., Q. M. Nhu, E. Zudaire, S. Polumuri, F. Cuttitta and S. N. Vogel: IFN regulatory factor-2 regulates macrophage apoptosis through a STAT1/3- and caspase-1- dependent mechanism. J Immunol 178, 3602-11 (2007) (Pubitemid 46417627)
10. Gamero, A. M., R. Potla, J. Wegrzyn, M. Szelag, A. E. Edling, K. Shimoda, D. C. Link, J. Dulak, D. P. Baker, Y. Tanabe, J. M. Grayson and A. C. Larner: Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-beta in primary pro-B cells. J Biol Chem 281,16238-44 (2006)
11. Chapman, R. S., P. Lourenco, E. Tonner, D. Flint, S. Selbert, K. Takeda, S. Akira, A. R. Clarke and C. J. Watson: The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv Exp Med Biol 480, 129-38 (2000) (Pubitemid 32176103)
12. Alonzi, T., D. Maritano, B. Gorgoni, G. Rizzuto, C. Libert and V. Poli: Essential role of STAT3 in the control of the acute-phase response as revealed by inducible geneinactivation [correction of activation] in the liver. Mol Cell Biol 21, 1621-32 (2001) (Pubitemid 32156382)
13. Alonzi, T., I. P. Newton, P. J. Bryce, E. Di Carlo, G. Lattanzio, M. Tripodi, P. Musiani and V. Poli: Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. Cytokine 26, 45-56 (2004) (Pubitemid 38410883)
14. Kobayashi, M., M. N. Kweon, H. Kuwata, R. D. Schreiber, H. Kiyono, K. Takeda and S. Akira: Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J Clin Invest 111, 1297-308 (2003) (Pubitemid 36554700)
15. Takeda, K., B. E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Forster and S. Akira: Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10, 39-49 (1999) (Pubitemid 29077382)
16. Caldenhoven, E., T. B. van Dijk, R. Solari, J. Armstrong, J. A. Raaijmakers, J. W. Lammers, L. Koenderman and R. P. de Groot: STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 271, 13221-7 (1996) (Pubitemid 26175904)
17. Schaefer, T. S., L. K. Sanders and D. Nathans: Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc Natl Acad Sci U S A 92, 9097-101 (1995)
18. Shao, H., A. J. Quintero and D. J. Tweardy: Identification and characterization of cis elements in the STAT3 gene regulating STAT3 alpha and STAT3 beta messenger RNA splicing. Blood 98, 3853-6 (2001)
19. Wen, Z., Z. Zhong and J. E. Darnell, Jr.: Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-50 (1995)
20. Biethahn, S., F. Alves, S. Wilde, W. Hiddemann and K. Spiekermann: Expression of granulocyte colonystimulating factor- and granulocyte-macrophage colonystimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia. Exp Hematol 27, 885-94 (1999) (Pubitemid 29231027)
21. Hevehan, D. L., W. M. Miller and E. T. Papoutsakis: Differential expression and phosphorylation of distinct STAT3 proteins during granulocytic differentiation. Blood 99, 1627-37 (2002) (Pubitemid 34533035)
22. Schaefer, T. S., L. K. Sanders, O. K. Park and D. Nathans: Functional differences between Stat3alpha and Stat3beta. Mol Cell Biol 17, 5307-16 (1997)
23. Park, O. K., L. K. Schaefer, W. Wang and T. S. Schaefer: Dimer stability as a determinant of differential DNA binding activity of Stat3 isoforms. J Biol Chem 275, 32244-9 (2000)
24. Huang, Y., J. Qiu, S. Dong, M. S. Redell, V. Poli, M. A. Mancini and D. J. Tweardy: STAT3 isoforms, alpha and beta , demonstrate distinct intracellular dynamics with prolonged nuclear retention of STAT3beta mapping to itsunique C-terminal end. J Biol Chem (2007)
25. Yoo, J. Y., D. L. Huso, D. Nathans and S. Desiderio: Specific ablation of Stat3beta distorts the pattern of Stat3- responsive gene expression and impairs recovery from endotoxic shock. Cell 108, 331-44 (2002) (Pubitemid 34178398)
26. Schuringa, J. J., H. Schepers, E. Vellenga and W. Kruijer: Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett 495, 71-6 (2001) (Pubitemid 32367976)
27. Karni, R., R. Jove and A. Levitzki: Inhibition of pp60c- Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene 18, 4654-62 (1999) (Pubitemid 29417740)
28. Sinibaldi, D., W. Wharton, J. Turkson, T. Bowman, W. J. Pledger and R. Jove: Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19, 5419-27 (2000) (Pubitemid 32000908)
29. Maritano, D., M. L. Sugrue, S. Tininini, S. Dewilde, B. Strobl, X. Fu, V. Murray-Tait, R. Chiarle and V. Poli: The STAT3 isoforms alpha and beta have unique and specific functions. Nat Immunol 5, 401-9 (2004) (Pubitemid 38500089)
30. Yang, X. P., K. Irani, S. Mattagajasingh, A. Dipaula, F. Khanday, M. Ozaki, K. Fox-Talbot, W. M. Baldwin, 3rd and L. C. Becker: Signal transducer and activator of transcription 3alpha and specificity protein 1 interact to upregulate intercellular adhesion molecule-1 in ischemicreperfused myocardium and vascular endothelium. Arterioscler Thromb Vasc Biol 25, 1395-400 (2005) (Pubitemid 40923358)
31. Yeh, M., N. M. Gharavi, J. Choi, X. Hsieh, E. Reed, K. P. Mouillesseaux, A. L. Cole, S. T. Reddy and J. A. Berliner: Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-src/signal transducers and activators of transcription (STAT)3 pathway. J Biol Chem 279, 30175-81 (2004) (Pubitemid 38937941)
32. de Koning, J. P., A. C. Ward, E. Caldenhoven, R. P. de Groot, B. Lowenberg and I. P. Touw: STAT3beta does not interfere with granulocyte colony-stimulating factorinduced neutrophilic differentiation. Hematol J 1, 220-5(2000)
33. Sasse, J., U. Hemmann, C. Schwartz, U. Schniertshauer, B. Heesel, C. Landgraf, J. Schneider- Mergener, P. C. Heinrich and F. Horn: Mutational analysis of acute-phase response factor/Stat3 activation and dimerization. Mol Cell Biol 17, 4677-86 (1997) (Pubitemid 27318143)
34. Zhang, X., M. H. Wrzeszczynska, C. M. Horvath and J. E. Darnell, Jr.: Interacting regions in Stat3 and c-Jun that participate in cooperative transcriptional activation. Mol Cell Biol 19, 7138-46 (1999) (Pubitemid 29441894)
35. Yoo, J. Y., W. Wang, S. Desiderio and D. Nathans: Synergistic activity of STAT3 and c-Jun at a specific array of DNA elements in the alpha 2-macroglobulin promoter. J Biol Chem 276, 26421-9 (2001)
36. Ivanov, V. N., M. Krasilnikov and Z. Ronai: Regulation of Fas expression by STAT3 and c-Jun is mediated by phosphatidylinositol 3-kinase-AKT signaling. J Biol Chem 277, 4932-44 (2002) (Pubitemid 34968531)
37. Nakashima, K., M. Yanagisawa, H. Arakawa, N. Kimura, T. Hisatsune, M. Kawabata, K. Miyazono and T. Taga: Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 284, 479-82 (1999) (Pubitemid 29289619)
38. Giraud, S., F. Bienvenu, S. Avril, H. Gascan, D. M. Heery and O. Coqueret: Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. J Biol Chem 277, 8004-11 (2002) (Pubitemid 34968252)
39. Schaefer, L. K., S. Wang and T. S. Schaefer: c-Src activates the DNA binding and transcriptional activity of Stat3 molecules: serine 727 is not required for transcriptional activation under certain circumstances. Biochem Biophys Res Commun 266, 481-7 (1999) (Pubitemid 30028693)
40. Lutticken, C., P. Coffer, J. Yuan, C. Schwartz, E. Caldenhoven, C. Schindler, W. Kruijer, P. C. Heinrich and F. Horn: Interleukin-6-induced serine phosphorylation of transcription factor APRF: evidence for a role in interleukin-6 target gene induction. FEBS Lett 360, 137-43 (1995)
41. Wen, Z. and J. E. Darnell, Jr.: Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res 25, 2062-7 (1997) (Pubitemid 27303439)
42. Chung, J., E. Uchida, T. C. Grammer and J. Blenis: STAT3 serine phosphorylation by ERK-dependent and - independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17, 6508-16 (1997) (Pubitemid 27451197)
43. Frank, D. A.: STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett 251, 199-210 (2007) (Pubitemid 46680370)
44. Turkson, J. and R. Jove: STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 19, 6613-26 (2000) (Pubitemid 32197700)
45. Turkson, J., T. Bowman, R. Garcia, E. Caldenhoven, R. P. De Groot and R. Jove: Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol 18, 2545-52 (1998) (Pubitemid 28183424)
46. Bromberg, J. F., C. M. Horvath, D. Besser, W. W. Lathem and J. E. Darnell, Jr.: Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol 18, 2553-8 (1998) (Pubitemid 28183425)
47. Catlett-Falcone, R., T. H. Landowski, M. M. Oshiro, J. Turkson, A. Levitzki, R. Savino, G. Ciliberto, L. Moscinski, J. L. Fernandez-Luna, G. Nunez, W. S. Dalton and R. Jove: Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105-15 (1999) (Pubitemid 29077388)
48. Zhang, Y. W., L. M. Wang, R. Jove and G. F. Vande Woude: Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis. Oncogene 21, 217-26 (2002) (Pubitemid 34102130)
49. Burke, W. M., X. Jin, H. J. Lin, M. Huang, R. Liu, R. K. Reynolds and J. Lin: Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells. Oncogene 20, 7925-34 (2001) (Pubitemid 34002969)
50. Cheng, L., S. Wang, Y. J. Ye, J. Q. Zhang, X. M. Qiao, D. Q. Yang and Z. R. Cui: [The effect of transfecting Stat3beta cDNA on human breast cancer]. Zhonghua Yi Xue Za Zhi 85, 23-7 (2005) (Pubitemid 40253851)
51. Rivat, C., S. Rodrigues, E. Bruyneel, G. Pietu, A. Robert, G. Redeuilh, M. Bracke, C. Gespach and S. Attoub: Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3) -and vascular endothelial growth factor-mediated cellular invasion and tumor growth. Cancer Res 65, 195-202 (2005)
52. Niu, G., R. Heller, R. Catlett-Falcone, D. Coppola, M. Jaroszeski, W. Dalton, R. Jove and H. Yu: Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res 59, 5059-63 (1999) (Pubitemid 29503958)
53. Niu, G., K. H. Shain, M. Huang, R. Ravi, A. Bedi, W. S. Dalton, R. Jove and H. Yu: Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. Cancer Res 61, 3276-80 (2001) (Pubitemid 32695012)
54. Wang, T., G. Niu, M. Kortylewski, L. Burdelya, K. Shain, S. Zhang, R. Bhattacharya, D. Gabrilovich, R. Heller, D. Coppola, W. Dalton, R. Jove, D. Pardoll and H. Yu: Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 10, 48-54 (2004) (Pubitemid 38524698)
55. Chakraborty, A., K. F. Dyer, M. Cascio, T. A. Mietzner and D. J. Tweardy: Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor. Blood 93, 15-24 (1999) (Pubitemid 29019383)
56. Panopoulos, A. D., L. Zhang, J. W. Snow, D. M. Jones, A. M. Smith, K. C. El Kasmi, F. Liu, M. A. Goldsmith, D. C. Link, P. J. Murray and S. S. Watowich: STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 108, 3682-90 (2006) (Pubitemid 44864545)
57. McLemore, M. L., S. Grewal, F. Liu, A. Archambault, J. Poursine-Laurent, J. Haug and D. C. Link: STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14, 193-204 (2001) (Pubitemid 32206521)
58. Croker, B. A., D. Metcalf, L. Robb, W. Wei, S. Mifsud, L. DiRago, L. A. Cluse, K. D. Sutherland, L. Hartley, E. Williams, J. G. Zhang, D. J. Hilton, N. A. Nicola, W. S. Alexander and A. W. Roberts: SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20, 153-65 (2004) (Pubitemid 38258392)
59. Kamezaki, K., K. Shimoda, A. Numata, T. Haro, H. Kakumitsu, M. Yoshie, M. Yamamoto, K. Takeda, T. Matsuda, S. Akira, K. Ogawa and M. Harada: Roles of Stat3 and ERK in G-CSF signaling. Stem Cells 23, 252-63 (2005) (Pubitemid 40239520)
60. Chakraborty, A., S. M. White, T. S. Schaefer, E. D. Ball, K. F. Dyer and D. J. Tweardy: Granulocyte colonystimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells. Blood 88, 2442-9 (1996) (Pubitemid 26327492)
61. Redell, M. S., A. Tsimelzon, S. G. Hilsenbeck and D. J. Tweardy: Conditional overexpression of Stat3alpha in differentiating myeloid cells results in neutrophil expansion and induces a distinct, antiapoptotic and pro-oncogenic gene expression pattern. J Leukoc Biol 82, 975-85 (2007) (Pubitemid 47511058)
62. Mackiewicz, A., M. Wiznerowicz, E. Roeb, A. Karczewska, J. Nowak, P. C. Heinrich and S. Rose-John: Soluble interleukin 6 receptor is biologically active in vivo. Cytokine 7, 142-9 (1995)
63. Alonzi, T., G. Middleton, S. Wyatt, V. Buchman, U. A. Betz, W. Muller, P. Musiani, V. Poli and A. M. Davies: Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons. Mol Cell Neurosci 18, 270-82 (2001) (Pubitemid 33027932)
64. Vercelli, A., M. Repici, D. Garbossa and A. Grimaldi: Recent techniques for tracing pathways in the central nervous system of developing and adult mammals. Brain Res Bull 51, 11-28 (2000) (Pubitemid 30029063)
65. Shen, Y., K. Schlessinger, X. Zhu, E. Meffre, F. Quimby, D. E. Levy and J. E. Darnell, Jr.: Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylation. Mol Cell Biol 24, 407-19 (2004) (Pubitemid 38010065)
66. Sano, S., Y. Takahama, T. Sugawara, H. Kosaka, S. Itami, K. Yoshikawa, J. Miyazaki, W. van Ewijk and J. Takeda: Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival. Immunity 15, 261-73 (2001) (Pubitemid 32816875)
67. Bridges, J. P. and T. E. Weaver: Use of transgenic mice to study lung morphogenesis and function. Ilar J 47, 22-31 (2006) (Pubitemid 43013509)
68. Hamvas, A.: Inherited surfactant protein-B deficiency and surfactant protein-C associated disease: clinical features and evaluation. Semin Perinatol 30, 316-26 (2006) (Pubitemid 44827225)
69. Clark, J. C., S. E. Wert, C. J. Bachurski, M. T. Stahlman, B. R. Stripp, T. E. Weaver and J. A. Whitsett: Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci U S A 92, 7794-8 (1995)
70. Yan, C., A. Naltner, M. Martin, M. Naltner, J. M. Fangman and O. Gurel: Transcriptional stimulation of the surfactant protein B gene by STAT3 in respiratory epithelial cells. J Biol Chem 277, 10967-72 (2002) (Pubitemid 34952852)
71. Hokuto, I., M. Ikegami, M. Yoshida, K. Takeda, S. Akira, A. K. Perl, W. M. Hull, S. E. Wert and J. A. Whitsett: Stat-3 is required for pulmonary homeostasis during hyperoxia. J Clin Invest 113, 28-37 (2004) (Pubitemid 38541629)
72. Niu, G., K. L. Wright, M. Huang, L. Song, E. Haura, J. Turkson, S. Zhang, T. Wang, D. Sinibaldi, D. Coppola, R. Heller, L. M. Ellis, J. Karras, J. Bromberg, D. Pardoll, R. Jove and H. Yu: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21, 2000-8 (2002) (Pubitemid 34270888)
73. DeChiara, T. M., R. Vejsada, W. T. Poueymirou, A. Acheson, C. Suri, J. C. Conover, B. Friedman, J. McClain, L. Pan, N. Stahl, N. Y. Ip and G. D. Yancopoulos: Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 83, 313-22 (1995)
74. Li, M., M. Sendtner and A. Smith: Essential function of LIF receptor in motor neurons. Nature 378, 724-7 (1995) (Pubitemid 26001944)
75. Bonni, A., Y. Sun, M. Nadal-Vicens, A. Bhatt, D. A. Frank, I. Rozovsky, N. Stahl, G. D. Yancopoulos and M. E. Greenberg: Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278,477-83 (1997) (Pubitemid 27454434)
76. Nakashima, K., S. Wiese, M. Yanagisawa, H. Arakawa, N. Kimura, T. Hisatsune, K. Yoshida, T. Kishimoto, M. Sendtner and T. Taga: Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J Neurosci 19, 5429-34 (1999) (Pubitemid 29300208)
77. Tramontin, A. D., J. M. Garcia-Verdugo, D. A. Lim and A. Alvarez-Buylla: Postnatal development of radial glia and the ventricular zone (VZ): a continuum of the neural stem cell compartment. Cereb Cortex 13, 580-7 (2003) (Pubitemid 36613164)